Discover 2,423 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,423
Protocol-driven Hemodynamic Support for Patients With Septic Shock
for
Shock, Septic, Severe Sepsis, Sepsis
Location: Baltimore MD
Sponsor: National Institute of General Medical Sciences (NIGMS)
Sex: All
Age: 18+
Code: NCT00335907
Recruiting
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
for
Hyperkalaemia
Location: Baltimore MD, Cincinnati OH, Columbia SC, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 0 - 18
Code: NCT03813407
Phase 3, Recruiting
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD
Sponsor: Johns Hopkins University
Sex: Male
Age: 18+
Code: NCT05792722
Recruiting
The Pediatric Anesthesia Quality Improvement Project
for
Surgery, Anesthesia, Children
Location: Washington DC, Baltimore MD, Hershey PA, Wilmington DE,
Sponsor: The Society for Pediatric Anesthesia
Sex: All
Age: 0 - 21
Code: NCT00674388
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Washington D.C. DC, McLean VA, Gaithersburg MD,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
for
Lung Cancer, Sarcoidosis
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT05171478
Recruiting
Human Upper Extremity Allotransplantation
for
Amputation, Traumatic, Wounds and Injuries, Hand Injuries
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18 - 69
Code: NCT01459107
Phase 2, Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)